S&P 500   4,297.14 (+0.40%)
DOW   33,912.44 (+0.45%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
S&P 500   4,297.14 (+0.40%)
DOW   33,912.44 (+0.45%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
S&P 500   4,297.14 (+0.40%)
DOW   33,912.44 (+0.45%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
S&P 500   4,297.14 (+0.40%)
DOW   33,912.44 (+0.45%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NASDAQ:ACHC

Acadia Healthcare - ACHC Stock Forecast, Price & News

$82.63
+0.02 (+0.02%)
(As of 08/15/2022 04:27 PM ET)
Add
Compare
Today's Range
$80.22
$82.80
50-Day Range
$63.69
$82.91
52-Week Range
$50.07
$83.63
Volume
408,199 shs
Average Volume
575,143 shs
Market Capitalization
$7.51 billion
P/E Ratio
27.09
Dividend Yield
N/A
Price Target
$81.89

Acadia Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
0.9% Downside
$81.89 Price Target
Short Interest
Bearish
3.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.38mentions of Acadia Healthcare in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$2.38 M Sold Last Quarter
Proj. Earnings Growth
7.03%
From $3.13 to $3.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

647th out of 1,125 stocks

Specialty Outpatient Clinics, Not Elsewhere Classified Industry

1st out of 3 stocks

ACHC stock logo

About Acadia Healthcare (NASDAQ:ACHC) Stock

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $1.20 during mid-day trading on Friday, hitting $82.61. 484,147 shares of the company's stock traded hands, compared to its average volume of 627,508. The firm has a 50 day moving average of $73.79 and a two-hundred day moving average of $67.99. Acadia Healthcare has a 12 month low of $50.07 and a 12 month high of $83.63. The firm has a market capitalization of $7.50 billion, a price-to-earnings ratio of 27.09, a price-to-earnings-growth ratio of 2.12 and a beta of 1.30. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.52.

Acadia Healthcare (NASDAQ:ACHC - Get Rating) last announced its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. Acadia Healthcare had a return on equity of 10.34% and a net margin of 11.32%. The firm had revenue of $651.72 million during the quarter, compared to the consensus estimate of $650.80 million. During the same quarter in the prior year, the company earned $0.71 EPS. The firm's revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities analysts forecast that Acadia Healthcare will post 3.13 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on ACHC. Jefferies Financial Group boosted their target price on Acadia Healthcare from $85.00 to $95.00 in a research note on Thursday, July 28th. Deutsche Bank Aktiengesellschaft upped their price target on Acadia Healthcare from $70.00 to $82.00 in a research note on Monday, August 1st. UBS Group upped their price target on Acadia Healthcare from $82.00 to $90.00 and gave the stock a "buy" rating in a research note on Thursday, July 28th. Loop Capital started coverage on Acadia Healthcare in a research note on Thursday, June 16th. They set a "hold" rating and a $72.00 price target for the company. Finally, Mizuho upped their price target on Acadia Healthcare from $64.00 to $69.00 in a research note on Wednesday, May 4th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $81.89.

Insider Activity at Acadia Healthcare

In other Acadia Healthcare news, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the transaction, the director now owns 31,769 shares of the company's stock, valued at approximately $2,650,169.98. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Christopher L. Howard sold 12,214 shares of the firm's stock in a transaction on Monday, August 8th. The stock was sold at an average price of $81.67, for a total value of $997,517.38. Following the completion of the transaction, the executive vice president now directly owns 149,147 shares of the company's stock, valued at $12,180,835.49. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William M. Petrie sold 6,000 shares of the firm's stock in a transaction on Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the transaction, the director now directly owns 31,769 shares of the company's stock, valued at $2,650,169.98. The disclosure for this sale can be found here. Insiders sold a total of 29,094 shares of company stock worth $2,375,868 in the last 90 days. 1.90% of the stock is owned by company insiders.

Receive ACHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acadia Healthcare and its competitors with MarketBeat's FREE daily newsletter.

ACHC Stock News Headlines

Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $82.00
Acadia Healthcare (NASDAQ:ACHC) PT Raised to $90.00
See More Headlines
Receive ACHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acadia Healthcare and its competitors with MarketBeat's FREE daily newsletter.

ACHC Company Calendar

Last Earnings
7/27/2022
Today
8/15/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
Health Care Facilities
Sector
Medical
Current Symbol
NASDAQ:ACHC
CUSIP
00404A10
Employees
22,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$81.89
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$69.00
Forecasted Upside/Downside
-0.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$190.63 million
Pretax Margin
15.12%

Debt

Sales & Book Value

Annual Sales
$2.31 billion
Cash Flow
$3.81 per share
Book Value
$27.99 per share

Miscellaneous

Free Float
89,115,000
Market Cap
$7.51 billion
Optionable
Optionable
Beta
1.30

Key Executives

  • Mr. David M. Duckworth (Age 42)
    Chief Financial Officer
    Comp: $1.71M
  • Mr. John S. Hollinsworth (Age 58)
    Exec. VP of Operations
    Comp: $1.59M
  • Mr. Christopher L. Howard (Age 55)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.55M
  • Mr. Laurence L. Harrod (Age 65)
    Exec. VP of Fin.
    Comp: $1.92M
  • Mr. Christopher Howal Hunter (Age 54)
    CEO & Director
  • Gretchen Hommrich
    VP of Investor Relations
  • Dr. Anne Kelly B.S.N.
    Ed.D., Chief Quality & Compliance Officer
  • Mr. Andrew Honeybone
    Sr. VP of HR
  • Ms. Isa Diaz
    Sr. VP of Strategic Affairs
  • Dr. Michael Genovese J.D.
    M.D., Chief Medical Officer













ACHC Stock - Frequently Asked Questions

Should I buy or sell Acadia Healthcare stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACHC shares.
View ACHC analyst ratings
or view top-rated stocks.

What is Acadia Healthcare's stock price forecast for 2022?

5 Wall Street analysts have issued 1-year target prices for Acadia Healthcare's shares. Their ACHC share price forecasts range from $69.00 to $95.00. On average, they expect the company's share price to reach $81.89 in the next twelve months. This suggests that the stock has a possible downside of 0.9%.
View analysts price targets for ACHC
or view top-rated stocks among Wall Street analysts.

How have ACHC shares performed in 2022?

Acadia Healthcare's stock was trading at $60.70 at the beginning of 2022. Since then, ACHC shares have increased by 36.1% and is now trading at $82.64.
View the best growth stocks for 2022 here
.

When is Acadia Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our ACHC earnings forecast
.

How were Acadia Healthcare's earnings last quarter?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) posted its quarterly earnings results on Wednesday, July, 27th. The company reported $0.84 EPS for the quarter, topping analysts' consensus estimates of $0.77 by $0.07. The company had revenue of $651.72 million for the quarter, compared to analyst estimates of $650.80 million. Acadia Healthcare had a trailing twelve-month return on equity of 10.34% and a net margin of 11.32%. Acadia Healthcare's revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the company earned $0.71 EPS.

What guidance has Acadia Healthcare issued on next quarter's earnings?

Acadia Healthcare issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $2.93-$3.18 for the period, compared to the consensus EPS estimate of $3.01. The company issued revenue guidance of $2.56 billion-$2.60 billion, compared to the consensus revenue estimate of $2.59 billion.

What is Debra K. Osteen's approval rating as Acadia Healthcare's CEO?

41 employees have rated Acadia Healthcare Chief Executive Officer Debra K. Osteen on Glassdoor.com. Debra K. Osteen has an approval rating of 36% among the company's employees. This puts Debra K. Osteen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Acadia Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acadia Healthcare investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), American Airlines Group (AAL), Archer-Daniels-Midland (ADM), Athabasca Oil (ATH), Aegean Marine Petroleum Network (ANW), Broadcom (AVGO), Exxon Mobil (XOM) and Colfax (CFX).

What is Acadia Healthcare's stock symbol?

Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."

Who are Acadia Healthcare's major shareholders?

Acadia Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (4.43%), William Blair Investment Management LLC (4.15%), FMR LLC (2.69%), Stephens Investment Management Group LLC (1.76%), Loomis Sayles & Co. L P (1.41%) and Aristotle Capital Boston LLC (1.24%). Insiders that own company stock include Christopher L Howard, David M Duckworth, Debra K Osteen, John S Hollinsworth, Reeve B Waud and William M Petrie.
View institutional ownership trends
.

How do I buy shares of Acadia Healthcare?

Shares of ACHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acadia Healthcare's stock price today?

One share of ACHC stock can currently be purchased for approximately $82.64.

How much money does Acadia Healthcare make?

Acadia Healthcare (NASDAQ:ACHC) has a market capitalization of $7.51 billion and generates $2.31 billion in revenue each year. The company earns $190.63 million in net income (profit) each year or $3.05 on an earnings per share basis.

How many employees does Acadia Healthcare have?

The company employs 22,500 workers across the globe.

How can I contact Acadia Healthcare?

Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The official website for the company is www.acadiahealthcare.com. The company can be reached via phone at (615) 861-6000 or via fax at 615-261-9685.

This page (NASDAQ:ACHC) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.